Bernard John Gersh

Duke University

Public scientific profile · Unclaimed

Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.

Top expertise

  • Atrial Fibrillation Management and Outcomes

    Strong evidence · 8 supporting papers · latest 2026

  • Mechanical Circulatory Support Devices

    Solid evidence · 1 supporting paper · latest 2026

  • ECG Monitoring and Analysis

    Solid evidence · 4 supporting papers · latest 2026

  • Acute Myocardial Infarction Research

    Solid evidence · 3 supporting papers · latest 2026

  • Cardiovascular Disease and Adiposity

    Solid evidence · 3 supporting papers · latest 2026

  • Cardiovascular Function and Risk Factors

    Solid evidence · 3 supporting papers · latest 2026

  • Venous Thromboembolism Diagnosis and Management

    Solid evidence · 1 supporting paper · latest 2014

  • Pharmaceutical industry and healthcare

    Solid evidence · 1 supporting paper · latest 2014

Publications (15)

  • Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

    2014DOIPMID 25173533

  • Erratum to ‘Trends, Predictors, and Outcomes of Temporary Mechanical Circulatory Support for Postcardiac Surgery Cardiogenic Shock’ [The American Journal of Cardiology 123(2019) Pages 489-497]

    2026DOIPMID 41724200

  • Artificial intelligence 12-lead electrocardiography to determine atrial fibrillation risk among UK Biobank participants with predisposing conditions

    2026DOIPMID 41815107

  • Multimorbidity in Atrial Fibrillation: Impact on Outcomes

    2026DOIPMID 41733064

  • PO-FPI-304 ASSOCIATION BETWEEN PERI-CORONARY FAT ATTENUATION INDEX AND ATRIAL FIBRILLATION RECURRENCE FOLLOWING PULMONARY VEIN ISOLATION

    2026DOI

  • Accumulation of chronic conditions in patients aged <65 years diagnosed with atrial fibrillation

    2026DOIPMID 42471207

  • Artificial intelligence 12-lead electrocardiography to determine atrial fibrillation risk among UK Biobank participants with predisposing conditions.

    2026DOI

  • Prediction of Heart Failure With Reduced Ejection Fraction With Artificial Intelligence Electrocardiography in Patients With Atrial Fibrillation

    2026DOIPMID 41939527

  • 26-A-14162-ACC LONG TERM REMODELING AND RISK OF HEART FAILURE AFTER TYPE 1 NON-ST ELEVATION MYOCARDIAL INFARCTION

    2026DOI

  • Abstract 4359102: Trends in Incidence of Atrial Fibrillation in the Midwest USA from 2013 to 2023

    2025DOI

  • Predicting decline in left ventricular function after new-onset left bundle branch block

    2025DOIPMID 41265768

  • Historical account of reperfusion therapy and the development of cardioprotection beyond reperfusion

    2026DOIPMID 42469452

  • 26-A-14153-ACC INR RARELY >1.5 IN PATIENTS ON APIXABAN: RESULTS FROM THE ARISTOTLE TRIAL

    2026DOI

  • Time-Critical Cardiovascular Risk After COVID-19: A Population-Based Analysis Across Variant Eras

    2026DOIPMID 42158619

  • In memoriam: Amir Lerman 1956–2026

    2026DOIPMID 42680180

Organizations in sourced records

Affiliation evidence only — not confirmed current employment.

  • Duke University

Source: OpenAlex · retrieved 2026-09-29

Are you Bernard John Gersh? Sign in to claim this profile